14 December 2025 : Clinical Research
The Silent Face of Chronic Hepatitis B: Biopsy-Supported Fibrosis Detection and the Reliability of Non-Invasive Scores (FIB-4, APRI) in Inactive, Gray Zone, and Immune-Tolerant Cases
Mehmet Kasım AydınDOI: 10.12659/MSM.951084
Med Sci Monit 2025; 31:e951084
Table 2 Comparison of FIB-4 and APRI scores according to fibrosis stage in the patients (n=230).
| Fibrosis score <3n=184 | Fibrosis score ≥3n=46 | P value | |
|---|---|---|---|
| Mean±SD | Mean±SD | ||
| FIB-4 | 0.91±0.55 | 1.53±0.90 | 0.003 |
| APRI | 0.29±0.15 | 0.44±0.23 | 0.001 |
| Based on -test, a value less than 0.05 was considered statistically significant. APRI – Aspartate Aminotransferase-to-Platelet Ratio Index; FIB-4 – Fibrosis-4 Index. | |||






